Africa currently imports more than 95% of its vaccines and 70% of its medicines, leaving the continent structurally dependent on foreign supply chains for basic healthcare needs. This vulnerability was exposed by the COVID-19 pandemic, prompting an absolute priority to build regional health sovereignty. Leaders across the continent are now working toward a target of locally producing 60% of Africa’s vaccine supply by 2040.
Economic Realities Driving African Vaccine Manufacturing
Economic data highlights the urgency of moving away from international aid and toward a self-sustaining regional health market. According to Ghana Minister of Health Kwabena Mintah Akandoh, Africa accounts for 17% of the world’s population and 25% of global vaccine demand, yet produces less than 1% of its own supply. Speaking on market projections, Akandoh noted that the African vaccine market is currently valued at $1.3 billion and is expected to reach $4.3 billion by 2030. Concurrently, official development assistance for health declined by 4.7% between 2021 and 2025, making self-financing an absolute necessity for the continent.
Achieving this transition requires an overhaul of the entire healthcare ecosystem, spanning research, clinical trials, regulatory alignment, manufacturing infrastructure, and commercial distribution. Zambian President Hakainde Hichilema emphasized that partial solutions are insufficient to protect populations during global health crises. According to Hichilema, countries like Ghana, Rwanda, Egypt, and South Africa have strengthened regional production, but current efforts must scale up significantly to establish end-to-end manufacturing capacity.
Regulatory Standards and International Competitiveness
To secure long-term investments and build consumer confidence, African leaders stress that locally manufactured products must adhere to stringent international benchmarks. Ethiopian Minister of Health Macdes Daba stated that products manufactured in Africa will not be subject to inferior standards. According to Daba, the continent is committed to producing, consuming, and sharing quality medicines that set high manufacturing standards at both continental and global levels.
Experts emphasize that Africa’s health emancipation relies on unified political will and rigorous regulatory frameworks. Shifting away from an import-dependent model provides a vital lever of resilience against future global disruptions, transforming a persistent public health challenge into a foundation for sustainable economic development.
>Related reading